<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               4 CONTRAINDICATIONS<BR>               <BR>                  SELZENTRY should not be used in patients with severe renal impairment or end-stage renal disease (ESRD) (CrCl <30 mL/min) who are taking potent CYP3A inhibitors or inducers.<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           SELZENTRY should not be used in patients with severe renal impairment or end-stage renal disease (ESRD) (CrCl <30Â mL/min) who are taking potent CYP3A inhibitors or inducers. (4)<BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>